Atlante Ventures
VC Fund
Milano, Italy
Atlante Ventures is a leading Italian VC fund, operated by IMI Fondi Chiusi SGR, part of Intesa Sanpaolo Group. Totalling, together with its companion funds Atlante Ventures Mezzogiorno (AVM) and Atlante Seed, 60 mio euros in funds under management, Atlante Ventures only supports truly innovative startups, in Italy and abroad. Since inception from 2007, Atlante Ventures, AVM and Atlante Seeds have invested in more than 20 seed and early stage companies across all the innovation spectrum, among which Silicon Biosystems, the leading single-cell genomics company, Icoolhunt, the online trend forecasting startup, Admantx, the semantic-based advertising optimization platform Through its dedicated team of 8 professionales, Atlante Ventures sifts through hundreds of startup companies per year, using the following as key investment criteria: existence of a clearly innovative product or method, strong IP and Know how where applicable, an entrepreneurial team possessing dynamism, common sense, selling skills and in general, the will to make their mark
- Total investments:
- 46
- Last investment:
- Lead investor:
- 22%
- Fund size:
- $37M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Atlante Ventures invests in
Stages Atlante Ventures invests in
Countries Atlante Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $150k–$3.5M
- Venture - Series Unknown
- $1.9M–$2.4M
Investment Focus
Industry
- Software 9 (20%)
- Hardware 4 (9%)
- Biotechnology 4 (9%)
- Analytics 3 (7%)
- Health Care 3 (7%)
Stage
- Funding Round 11 (24%)
- Seed 7 (15%)
- Venture - Series Unknown 6 (13%)
- Series A 5 (11%)
- Series B 2 (4%)
Country
- Italy 16 (35%)
- United States 2 (4%)
- Israel 1 (2%)
- Belgium 1 (2%)
- United Kingdom 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Alberto Villa
Investment Analyst
|
Investment Analyst | Total investments: 3 | Find email | |
Alvise Bonivento
Senior Investment Manager
|
Senior Investment Manager | Total investments: 16 | Find email | |
Giovanni De Caro
Investment Manager
|
Investment Manager | Total investments: 0 | Find email | |
Andrea Ballestri
Investment Director
|
Investment Director | Total investments: 3 | Find email | |
|
Antonella Beltrame
Investment Director
|
Investment Director | Total investments: 6 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Treet launched their own completely branded peer-to-peer resale platform to assist fashion firms in becoming more circular and in controlling the secondary market for the products they make. In order to buy and sell used goods from one another, customers of Treet Marketplaces use a secondary website that accepts payments in the form of cash orbrand credit. While brands split the profits, Treet takes care of all the logistics and support.Treet was established in 2021 by Jake Disraeli and Sonia Yang in San Francisco, California. | $3.5M / Seed / Oct 13, 2022 | ||
| WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper. | $17.6M / Series C / Oct 01, 2020 | ||
| UltraSoC Technologies is an independent provider of SoC infrastructure to enable rapid development of embedded systems based on advanced SoC devices. Its head office is in Cambridge and it has research and development labs in Colchester. | $6.4M / Series D / May 26, 2017 | ||
| WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper. | $7.1M / Series B / May 25, 2017 | ||
| Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies. | $1.9M / Venture - Series Unknown / Jun 14, 2016 | ||
| Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies. | Seed / Mar 01, 2016 | ||
| Pi-Cardia is a medical device start-up company developing a novel low profile catheter for the treatment of aortic stenosis. The company's proprietary technology is based on delivering mechanical impact for creating fractures in valve calcifications, without injuring the surrounding soft tissue. This treatment, which only takes severalseconds, is intended to increase the valve effective orifice area without the need to replace the valve. | $10M / Series C / Jan 07, 2016 | ||
| A NEW ERA OF AUDIENCE TARGETINGADmantX is a contextual analysis and data provider that brings audience targeting to a new level. Awarded patent for semantic advertising technology, the company offers a cookie-less solution that allows publishers, ad networks and exchanges, brand managers and agencies to develop more effective online adcampaigns leveraging semantic understanding, natural language processing and sentiment analysis. Founded in Italy as a spin-off of the leading semantic company Expert System, ADmantX is active in Europe and US. Worldwide customers include NBCUniversal, Integral Ad Science, Networked Insights, Banzai, Cadreon, Amnet, Sojern, Media IQ and ADmantX solutions are integrated in key DSP players such as Turn, Adform and AppNexus. | $2.3M / Venture - Series Unknown / Sep 16, 2015 | ||
| Pi-Cardia is a medical device start-up company developing a novel low profile catheter for the treatment of aortic stenosis. The company's proprietary technology is based on delivering mechanical impact for creating fractures in valve calcifications, without injuring the surrounding soft tissue. This treatment, which only takes severalseconds, is intended to increase the valve effective orifice area without the need to replace the valve. | Series C / Sep 01, 2015 | ||
| WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper. | $3.4M / Series A / Jun 09, 2015 | ||
| See all 46 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Atlante Ventures invest in?
Atlante Ventures invests primarily in Software, Hardware and Biotechnology startups, most often at Funding Round and Seed stage. Most of the 46 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Atlante Ventures invest in?
Atlante Ventures typically joins rounds of $150k–$3.5M at Seed and $1.9M–$2.4M at Venture - Series Unknown. These are whole funding-round sizes, not Atlante Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Atlante Ventures took part in.
How do I contact Atlante Ventures?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Atlante Ventures?
The team at Atlante Ventures includes Alberto Villa (Investment Analyst), Alvise Bonivento (Senior Investment Manager) and Giovanni De Caro (Investment Manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
